Gastroenterology society bestows ‘shark tank’ honor to Montreal firm The Society of American Gastrointestinal and Endoscopic ...

A minimally invasive therapy, the TIF 2.0 procedure reconstructs the gastroesophageal valve and restores its function as a reflux barrier. TIF 2.0 can also be combined consecutively with a surgical ...

Northtowns Ambulatory Surgery Center (ASC), a joint venture between Buffalo surgeons and Kaleida Health Ventures, has chosen Distalmotion’s DEXTER ® Robotic Surgery System as its outpatient surgical ...

Cabozantinib, an oral tyrosine kinase inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with previously treated advanced neuroendocrine tumors ...